title: Late immune tolerance induction in an adult with severe haemophilia A and high-responder inhibitor: 1-year outcome.
authors: A
authors: A
authors: Faradji
authors: G
authors: G
authors: Lavigne-Lissalde
authors: L
authors: L
authors: Grunebaum
authors: D
authors: D
authors: Desprez
authors: O
authors: O
authors: Feugeas
authors: P
authors: P
authors: Lapalud
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D019774:Blood Coagulation Factor Inhibitors / Q000097:blood* / Q000276:immunology; D005169:Factor VIII / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000276:immunology*; D006467:Hemophilia A / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D007108:Immune Tolerance; D007165:Immunosuppression Therapy / Q000379:methods*; D008297:Male; D000069283:Rituximab; D013997:Time Factors
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D019774:Blood Coagulation Factor Inhibitors; D000069283:Rituximab; C078147:F8 protein, human; D005169:Factor VIII